{"transactions":[{"id":4615754,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":47009,"kind":"person","name":"Brennan David R","position":1,"cik":"0001609305","reported_name":"Brennan David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-11T20:04:46.000Z","date":"2026-09-09","kind":"sale","planned":false,"acquired":false,"shares":25000,"price":124,"value":3100000.0,"ownership":{"direct":true},"balance_after":39238,"source":{"system":"sec-edgar","filing":"0001609305-26-000009","document":"wk-form4_1789157083.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609305/000160930526000009/wk-form4_1789157083.xml","form_type":"4"}},{"id":777554,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":47009,"kind":"person","name":"Brennan David R","position":1,"cik":"0001609305","reported_name":"Brennan David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:07:14.000Z","date":"2026-05-13","kind":"grant","planned":false,"acquired":true,"shares":3305,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock. The RSUs vest in full on the first anniversary of the grant date (the Vesting Date), provided that the director (a) remains a member of the Board of Directors of the issuer until the earlier of (i) such Vesting Date and (ii) the Company's Annual Shareholder Meeting in the year of such Vesting Date, and (b) attends at least 75% of the meetings of the Board of Directors which take place between the grant date and the first anniversary of the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU was granted on May 13, 2026, for no consideration."}],"balance_after":64238,"source":{"system":"sec-edgar","filing":"0001609305-26-000004","document":"wk-form4_1778875632.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000160930526000004/wk-form4_1778875632.xml","form_type":"4"}},{"id":882409,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":47009,"kind":"person","name":"Brennan David R","position":1,"cik":"0001609305","reported_name":"Brennan David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-25T21:04:19.000Z","date":"2026-02-23","kind":"gift","planned":false,"acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":60933,"source":{"system":"sec-edgar","filing":"0001609305-26-000002","document":"wk-form4_1772053457.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000160930526000002/wk-form4_1772053457.xml","form_type":"4"}},{"id":1004126,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":47009,"kind":"person","name":"Brennan David R","position":1,"cik":"0001609305","reported_name":"Brennan David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-10T21:42:41.000Z","date":"2025-11-06","kind":"gift","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By spouse revocable trust"},"balance_after":60000,"source":{"system":"sec-edgar","filing":"0001609305-25-000004","document":"wk-form4_1762810957.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000160930525000004/wk-form4_1762810957.xml","form_type":"4"}},{"id":1004125,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":47009,"kind":"person","name":"Brennan David R","position":1,"cik":"0001609305","reported_name":"Brennan David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-10T21:42:41.000Z","date":"2025-11-06","kind":"gift","planned":false,"acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":66933,"source":{"system":"sec-edgar","filing":"0001609305-25-000004","document":"wk-form4_1762810957.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000160930525000004/wk-form4_1762810957.xml","form_type":"4"}},{"id":1143494,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":47009,"kind":"person","name":"Brennan David R","position":1,"cik":"0001609305","reported_name":"Brennan David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-19T20:57:51.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":5058,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock. The RSUs have a one year cliff vesting period, provided that the director (a) remains a member of the Board of Directors of the issuer on such vesting date, and (b) attends at least 75% of the meetings of the Board of Directors which take place between the grant date and the first anniversary of the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU was granted on May 15, 2025 for no consideration."}],"balance_after":126933,"source":{"system":"sec-edgar","filing":"0001628280-25-026569","document":"wk-form4_1747688264.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000162828025026569/wk-form4_1747688264.xml","form_type":"4"}},{"id":1516301,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":47009,"kind":"person","name":"Brennan David R","position":1,"cik":"0001609305","reported_name":"Brennan David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-15T20:17:07.000Z","date":"2024-05-13","kind":"grant","planned":false,"acquired":true,"shares":13162,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock. The RSUs have a one year cliff vesting period, provided that the director (a) remains a member of the Board of Directors of the issuer on such vesting date, and (b) attends at least 75% of the meetings of the Board of Directors which take place between the grant date and the first anniversary of the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU was granted on May 13, 2024 for no consideration."}],"balance_after":121875,"source":{"system":"sec-edgar","filing":"0001628280-24-023560","document":"wk-form4_1715804216.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000162828024023560/wk-form4_1715804216.xml","form_type":"4"}},{"id":1893838,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":47009,"kind":"person","name":"Brennan David R","position":1,"cik":"0001609305","reported_name":"Brennan David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-15T20:21:51.000Z","date":"2023-05-11","kind":"grant","planned":false,"acquired":true,"shares":13192,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit was granted on May 11, 2023, for no consideration."}],"balance_after":108713,"source":{"system":"sec-edgar","filing":"0001628280-23-018200","document":"wf-form4_168418208788013.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000162828023018200/wf-form4_168418208788013.xml","form_type":"4"}},{"id":2272391,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":47009,"kind":"person","name":"Brennan David R","position":1,"cik":"0001609305","reported_name":"Brennan David R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-13T22:16:49.000Z","date":"2022-05-11","kind":"grant","acquired":true,"shares":14645,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit was granted on May 11, 2022, for no consideration."}],"balance_after":95521,"source":{"system":"sec-edgar","filing":"0001140361-22-019182","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000114036122019182/form4.xml","form_type":"4"}},{"id":2526987,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":47009,"kind":"person","name":"Brennan David R","position":1,"cik":"0001609305","reported_name":"Brennan David R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-11-03T20:27:27.000Z","date":"2021-11-01","kind":"purchase","acquired":true,"shares":10000,"price":30.15,"value":301500.0,"ownership":{"direct":true},"balance_after":80876,"source":{"system":"sec-edgar","filing":"0001140361-21-036422","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000114036121036422/form4.xml","form_type":"4"}},{"id":2626557,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":47009,"kind":"person","name":"Brennan David R","position":1,"cik":"0001609305","reported_name":"Brennan David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2021-07-23T16:44:13.000Z","date":"2021-07-21","kind":"disposition_to_issuer","acquired":false,"shares":2294,"price":138.86,"value":318544.84,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Upon the First Effective Time, these options were cancelled and converted into the right to receive the product obtained by multiplying (A) the excess, if any, of the value of the Merger Consideration over the exercise price per share of the Alexion common stock subject to such options immediately prior to the First Effective Time by (B) the number of shares of Alexion common stock subject to such option immediately prior to the First Effective Time by (ii) the value of the Merger Consideration."}],"balance_after":0,"derivative":{"exercise_price":138.86,"exercise_date":"2017-05-11","expiration_date":"2026-05-11","underlying":"Common Stock, par value $.0001 per share","underlying_shares":2294},"source":{"system":"sec-edgar","filing":"0000899866-21-000070","document":"wf-form4_162707303457502.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986621000070/wf-form4_162707303457502.xml","form_type":"4"}},{"id":2626556,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":47009,"kind":"person","name":"Brennan David R","position":1,"cik":"0001609305","reported_name":"Brennan David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2021-07-23T16:44:13.000Z","date":"2021-07-21","kind":"disposition_to_issuer","acquired":false,"shares":2706,"price":167.97,"value":454526.82,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Upon the First Effective Time, these options were cancelled and converted into the right to receive the product obtained by multiplying (A) the excess, if any, of the value of the Merger Consideration over the exercise price per share of the Alexion common stock subject to such options immediately prior to the First Effective Time by (B) the number of shares of Alexion common stock subject to such option immediately prior to the First Effective Time by (ii) the value of the Merger Consideration."}],"balance_after":0,"derivative":{"exercise_price":167.97,"exercise_date":"2015-07-22","expiration_date":"2024-07-22","underlying":"Common Stock, par value $.0001 per share","underlying_shares":2706},"source":{"system":"sec-edgar","filing":"0000899866-21-000070","document":"wf-form4_162707303457502.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986621000070/wf-form4_162707303457502.xml","form_type":"4"}},{"id":2626555,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":47009,"kind":"person","name":"Brennan David R","position":1,"cik":"0001609305","reported_name":"Brennan David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2021-07-23T16:44:13.000Z","date":"2021-07-21","kind":"disposition_to_issuer","acquired":false,"shares":2343,"price":155.01,"value":363188.43,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Upon the First Effective Time, these options were cancelled and converted into the right to receive the product obtained by multiplying (A) the excess, if any, of the value of the Merger Consideration over the exercise price per share of the Alexion common stock subject to such options immediately prior to the First Effective Time by (B) the number of shares of Alexion common stock subject to such option immediately prior to the First Effective Time by (ii) the value of the Merger Consideration."}],"balance_after":0,"derivative":{"exercise_price":155.01,"exercise_date":"2016-05-06","expiration_date":"2025-05-06","underlying":"Common Stock, par value $.0001 per share","underlying_shares":2343},"source":{"system":"sec-edgar","filing":"0000899866-21-000070","document":"wf-form4_162707303457502.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986621000070/wf-form4_162707303457502.xml","form_type":"4"}},{"id":2626554,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":47009,"kind":"person","name":"Brennan David R","position":1,"cik":"0001609305","reported_name":"Brennan David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $.0001 per share","published_at":"2021-07-23T16:44:13.000Z","date":"2021-07-21","kind":"disposition_to_issuer","acquired":false,"shares":20873,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Alexion common stock disposed in connection with the Agreement and Plan of Merger (the \"Merger Agreement\") dated as of December 12, 2020, by and among Alexion and AstraZeneca PLC. In accordance with the Merger Agreement, upon the First Effective Time (as defined in the Merger Agreement), each share of Alexion common stock was converted into the right to receive (i) 2.1423 American Depositary Shares (ADSs) of AstraZeneca PLC and (ii) $60.00 in cash (the \"Merger Consideration\").  Upon the First Effective Time, 3,336 restricted stock units were fully vested and cancelled and converted into the right to receive the Merger Consideration with respect to each share of Alexion common stock subject to such restricted stock units."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899866-21-000070","document":"wf-form4_162707303457502.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986621000070/wf-form4_162707303457502.xml","form_type":"4"}},{"id":2699674,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":47009,"kind":"person","name":"Brennan David R","position":1,"cik":"0001609305","reported_name":"Brennan David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $.0001 per share","published_at":"2021-05-24T16:25:48.000Z","date":"2021-05-20","kind":"grant","acquired":true,"shares":1374,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Award of Restricted Stock Units under the 2017 Incentive Plan. Shares issuable pursuant to the Restricted Stock Units vest as to 25% on a quarterly basis. These Restricted Stock Units were issued in lieu ofthe annual cash retainer that the director was entitled to receive for service as a director."}],"balance_after":20873,"source":{"system":"sec-edgar","filing":"0000899866-21-000040","document":"wf-form4_162188793114273.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986621000040/wf-form4_162188793114273.xml","form_type":"4"}},{"id":2699673,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":47009,"kind":"person","name":"Brennan David R","position":1,"cik":"0001609305","reported_name":"Brennan David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $.0001 per share","published_at":"2021-05-24T16:25:48.000Z","date":"2021-05-20","kind":"grant","acquired":true,"shares":1962,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units under the 2017 Incentive Plan. Shares issuable pursuant to the Restricted Stock Units vest in their entirety on the first anniversary of the grant date."}],"balance_after":19499,"source":{"system":"sec-edgar","filing":"0000899866-21-000040","document":"wf-form4_162188793114273.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986621000040/wf-form4_162188793114273.xml","form_type":"4"}},{"id":2712670,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":47009,"kind":"person","name":"Brennan David R","position":1,"cik":"0001609305","reported_name":"Brennan David R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-05-14T20:27:55.000Z","date":"2021-05-12","kind":"grant","acquired":true,"shares":7558,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit was granted on May 12, 2021 for no consideration."}],"balance_after":70876,"source":{"system":"sec-edgar","filing":"0001140361-21-017417","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000114036121017417/form4.xml","form_type":"4"}},{"id":3146183,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":47009,"kind":"person","name":"Brennan David R","position":1,"cik":"0001609305","reported_name":"Brennan David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $.0001 per share","published_at":"2020-05-18T17:22:30.000Z","date":"2020-05-14","kind":"grant","acquired":true,"shares":2428,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Award of Restricted Stock Units under the 2017 Incentive Plan. Shares issuable pursuant to the Restricted Stock Units vest as to 25% on a quarterly basis. These Restricted Stock Units were issued in lieu of the annual cash retainer that the director was entitled to receive for service as a director."}],"balance_after":17537,"source":{"system":"sec-edgar","filing":"0000899866-20-000050","document":"wf-form4_158983693305646.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986620000050/wf-form4_158983693305646.xml","form_type":"4"}},{"id":3146182,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":47009,"kind":"person","name":"Brennan David R","position":1,"cik":"0001609305","reported_name":"Brennan David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $.0001 per share","published_at":"2020-05-18T17:22:30.000Z","date":"2020-05-14","kind":"grant","acquired":true,"shares":3468,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units under the 2017 Incentive Plan. Shares issuable pursuant to the Restricted Stock Units vest in their entirety on the earlier of (i) the first anniversary of the grant date and (ii) the date of the 2021 Annual Shareholder Meeting."}],"balance_after":15109,"source":{"system":"sec-edgar","filing":"0000899866-20-000050","document":"wf-form4_158983693305646.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986620000050/wf-form4_158983693305646.xml","form_type":"4"}},{"id":3149265,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":47009,"kind":"person","name":"Brennan David R","position":1,"cik":"0001609305","reported_name":"Brennan David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-15T00:57:46.000Z","date":"2020-05-12","kind":"grant","acquired":true,"shares":8097,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit was granted on May 12, 2020 for no consideration."}],"balance_after":63318,"source":{"system":"sec-edgar","filing":"0001104659-20-061851","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000110465920061851/a4.xml","form_type":"4"}},{"id":3522267,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":47009,"kind":"person","name":"Brennan David R","position":1,"cik":"0001609305","reported_name":"Brennan David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $.0001 per share","published_at":"2019-05-17T16:42:21.000Z","date":"2019-05-15","kind":"grant","acquired":true,"shares":1908,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Award of Restricted Stock Units under the 2017 Incentive Plan. Shares issuable pursuant to the Restricted Stock Units vest as to 25% on a quarterly basis. These Restricted Stock Units were issued in lieu of the annual cash retainer that the director was entitled to receive for service as a director."}],"balance_after":11641,"source":{"system":"sec-edgar","filing":"0000899866-19-000073","document":"wf-form4_155812572607727.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986619000073/wf-form4_155812572607727.xml","form_type":"4"}},{"id":3522266,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":47009,"kind":"person","name":"Brennan David R","position":1,"cik":"0001609305","reported_name":"Brennan David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $.0001 per share","published_at":"2019-05-17T16:42:21.000Z","date":"2019-05-15","kind":"grant","acquired":true,"shares":2726,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units under the 2017 Incentive Plan. Shares issuable pursuant to the Restricted Stock Units vest in their entirety on the first anniversary of the grant date."}],"balance_after":9733,"source":{"system":"sec-edgar","filing":"0000899866-19-000073","document":"wf-form4_155812572607727.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986619000073/wf-form4_155812572607727.xml","form_type":"4"}},{"id":3524226,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":47009,"kind":"person","name":"Brennan David R","position":1,"cik":"0001609305","reported_name":"Brennan David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-16T21:16:44.000Z","date":"2019-05-15","kind":"grant","acquired":true,"shares":6899,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the vesting date. Vested shares are delivered within 30 days of vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit was granted on May 15, 2019, and represents a contingent right to receive one share of Common Stock."}],"balance_after":55221,"source":{"system":"sec-edgar","filing":"0001127430-19-000075","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743019000075/edgar.xml","form_type":"4"}},{"id":3928748,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":47009,"kind":"person","name":"Brennan David R","position":1,"cik":"0001609305","reported_name":"Brennan David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-17T20:13:28.000Z","date":"2018-05-15","kind":"grant","acquired":true,"shares":6066,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit was granted on May 15, 2018, and represents a contingent right to receive one share of Common Stock."}],"balance_after":48322,"source":{"system":"sec-edgar","filing":"0001127430-18-000038","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743018000038/edgar.xml","form_type":"4"}},{"id":3937742,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":47009,"kind":"person","name":"Brennan David R","position":1,"cik":"0001609305","reported_name":"Brennan David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $.0001 per share","published_at":"2018-05-11T16:16:16.000Z","date":"2018-05-09","kind":"grant","acquired":true,"shares":2174,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units under the 2017 Incentive Plan. Award vests on the anniversary of the grant date."}],"balance_after":7007,"source":{"system":"sec-edgar","filing":"0000899866-18-000096","document":"wf-form4_152606971378414.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986618000096/wf-form4_152606971378414.xml","form_type":"4"}},{"id":4250694,"issuer":{"id":12261,"kind":"organization","name":"Innocoll Holdings plc","symbol":"INNL"},"owners":[{"id":47009,"kind":"person","name":"Brennan David R","position":1,"cik":"0001609305","reported_name":"Brennan David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-07-26T23:04:27.000Z","date":"2017-07-24","kind":"disposition_to_issuer","acquired":false,"shares":14907,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Immediately prior to the Effective Time, the Reporting Person beneficially owned unexercised options to purchase 34,796 Ordinary Shares (the \"Options\"). Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, the Options were cancelled without any consideration being payable in respect thereof."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Immediately prior to the Effective Time, the Reporting Person beneficially owned unexercised options to purchase 34,796 Ordinary Shares (the \"Options\"). Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, the Options were cancelled without any consideration being payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Immediately prior to the Effective Time, the Reporting Person beneficially owned unexercised options to purchase 34,796 Ordinary Shares (the \"Options\"). Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, the Options were cancelled without any consideration being payable in respect thereof."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"Immediately prior to the Effective Time, the Reporting Person beneficially owned unexercised options to purchase 34,796 Ordinary Shares (the \"Options\"). Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, the Options were cancelled without any consideration being payable in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":8.8,"expiration_date":"2026-03-30","underlying":"Ordinary Shares, par value $0.01 per share","underlying_shares":14907},"source":{"system":"sec-edgar","filing":"0001144204-17-038449","document":"v471498_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1609305/000114420417038449/v471498_4.xml","form_type":"4"}},{"id":4250693,"issuer":{"id":12261,"kind":"organization","name":"Innocoll Holdings plc","symbol":"INNL"},"owners":[{"id":47009,"kind":"person","name":"Brennan David R","position":1,"cik":"0001609305","reported_name":"Brennan David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-07-26T23:04:27.000Z","date":"2017-07-24","kind":"disposition_to_issuer","acquired":false,"shares":8230,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Immediately prior to the Effective Time, the Reporting Person beneficially owned unexercised options to purchase 34,796 Ordinary Shares (the \"Options\"). Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, the Options were cancelled without any consideration being payable in respect thereof."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Immediately prior to the Effective Time, the Reporting Person beneficially owned unexercised options to purchase 34,796 Ordinary Shares (the \"Options\"). Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, the Options were cancelled without any consideration being payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Immediately prior to the Effective Time, the Reporting Person beneficially owned unexercised options to purchase 34,796 Ordinary Shares (the \"Options\"). Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, the Options were cancelled without any consideration being payable in respect thereof."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"Immediately prior to the Effective Time, the Reporting Person beneficially owned unexercised options to purchase 34,796 Ordinary Shares (the \"Options\"). Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, the Options were cancelled without any consideration being payable in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":8.8,"expiration_date":"2026-03-30","underlying":"Ordinary Shares, par value $0.01 per share","underlying_shares":8230},"source":{"system":"sec-edgar","filing":"0001144204-17-038449","document":"v471498_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1609305/000114420417038449/v471498_4.xml","form_type":"4"}},{"id":4250692,"issuer":{"id":12261,"kind":"organization","name":"Innocoll Holdings plc","symbol":"INNL"},"owners":[{"id":47009,"kind":"person","name":"Brennan David R","position":1,"cik":"0001609305","reported_name":"Brennan David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-07-26T23:04:27.000Z","date":"2017-07-24","kind":"disposition_to_issuer","acquired":false,"shares":11659,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Immediately prior to the Effective Time, the Reporting Person beneficially owned unexercised options to purchase 34,796 Ordinary Shares (the \"Options\"). Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, the Options were cancelled without any consideration being payable in respect thereof."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Immediately prior to the Effective Time, the Reporting Person beneficially owned unexercised options to purchase 34,796 Ordinary Shares (the \"Options\"). Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, the Options were cancelled without any consideration being payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Immediately prior to the Effective Time, the Reporting Person beneficially owned unexercised options to purchase 34,796 Ordinary Shares (the \"Options\"). Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, the Options were cancelled without any consideration being payable in respect thereof."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"Immediately prior to the Effective Time, the Reporting Person beneficially owned unexercised options to purchase 34,796 Ordinary Shares (the \"Options\"). Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, the Options were cancelled without any consideration being payable in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":8.8,"expiration_date":"2026-03-30","underlying":"Ordinary Shares, par value $0.01 per share","underlying_shares":11659},"source":{"system":"sec-edgar","filing":"0001144204-17-038449","document":"v471498_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1609305/000114420417038449/v471498_4.xml","form_type":"4"}},{"id":4250691,"issuer":{"id":12261,"kind":"organization","name":"Innocoll Holdings plc","symbol":"INNL"},"owners":[{"id":47009,"kind":"person","name":"Brennan David R","position":1,"cik":"0001609305","reported_name":"Brennan David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2017-07-26T23:04:27.000Z","date":"2017-07-24","kind":"disposition_to_issuer","acquired":false,"shares":237440,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Immediately prior to the Effective Time (as defined below), the Reporting Person beneficially owned 237,440 ordinary shares of the Issuer, par value $0.01 per share (\"Ordinary Shares\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Transaction Agreement by and among the Issuer, Gurnet Point L.P., a Delaware limited partnership acting through its general partner Waypoint International GP LLC (\"Gurnet Point\"), and Lough Ree Technologies Limited, an Irish private limited company and wholly-owned subsidiary of Gurnet Point (the \"Transaction Agreement\"), each Ordinary Share that was beneficially owned by the Reporting Person immediately prior to the effective time of the scheme (the \"Effective Time\") now represents the right to receive (i) $1.75 in cash and (ii) a contingent value right which represents a contractual right to receive payments up to a maximum aggregate amount of $4.90 in cash upon, and subject to, the occurrence of certain events, without interest and net of applicable tax withholdings."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Pursuant to the terms of the Transaction Agreement by and among the Issuer, Gurnet Point L.P., a Delaware limited partnership acting through its general partner Waypoint International GP LLC (\"Gurnet Point\"), and Lough Ree Technologies Limited, an Irish private limited company and wholly-owned subsidiary of Gurnet Point (the \"Transaction Agreement\"), each Ordinary Share that was beneficially owned by the Reporting Person immediately prior to the effective time of the scheme (the \"Effective Time\") now represents the right to receive (i) $1.75 in cash and (ii) a contingent value right which represents a contractual right to receive payments up to a maximum aggregate amount of $4.90 in cash upon, and subject to, the occurrence of certain events, without interest and net of applicable tax withholdings."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-17-038449","document":"v471498_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609305/000114420417038449/v471498_4.xml","form_type":"4"}},{"id":4312020,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":47009,"kind":"person","name":"Brennan David R","position":1,"cik":"0001609305","reported_name":"Brennan David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-19T20:28:53.000Z","date":"2017-05-17","kind":"grant","acquired":true,"shares":6702,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit was received as a grant on May 17, 2017, and represents a contingent right to receive one share of Common Stock."}],"balance_after":42256,"source":{"system":"sec-edgar","filing":"0001127430-17-000041","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743017000041/edgar.xml","form_type":"4"}},{"id":4323657,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":47009,"kind":"person","name":"Brennan David R","position":1,"cik":"0001609305","reported_name":"Brennan David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $.0001 per share","published_at":"2017-05-12T18:00:36.000Z","date":"2017-05-10","kind":"grant","acquired":true,"shares":2030,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"RSU's will vest 100% on the 1-year anniversary of the grant date."}],"balance_after":4833,"source":{"system":"sec-edgar","filing":"0000899866-17-000109","document":"wf-form4_149462642188594.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986617000109/wf-form4_149462642188594.xml","form_type":"4"}}]}